Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 3,675 Cr
P/E 35.90
Div Yield 0.10 %
Book Value βΉ83.90
52w High βΉ448.00
52w Low βΉ231.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
207.00
238.00
210.00
242.00
196.00
248.00
173.00
197.00
164.00
246.00
161.00
167.00
135.00
Expenses
165.00
198.00
167.00
194.00
157.00
207.00
140.00
165.00
131.00
212.00
133.00
139.00
109.00
Operating Profit
42.00
40.00
44.00
48.00
39.00
41.00
33.00
32.00
33.00
33.00
29.00
28.00
27.00
OPM %
20.00
17.00
21.00
20.00
20.00
17.00
19.00
16.00
20.00
14.00
18.00
17.00
20.00
Other Income
2.00
3.00
4.00
1.00
1.00
1.00
2.00
1.00
1.00
2.00
1.00
1.00
1.00
Depreciation
10.00
10.00
10.00
10.00
10.00
9.00
9.00
9.00
8.00
8.00
8.00
8.00
8.00
Interest
6.00
5.00
6.00
6.00
6.00
5.00
4.00
5.00
5.00
6.00
6.00
6.00
6.00
Profit before tax
28.00
27.00
31.00
34.00
24.00
29.00
23.00
20.00
22.00
22.00
16.00
15.00
13.00
Tax %
25.00
23.00
25.00
26.00
24.00
29.00
24.00
28.00
25.00
26.00
26.00
21.00
29.00
Net Profit
21.00
21.00
23.00
25.00
18.00
21.00
17.00
14.00
16.00
16.00
12.00
12.00
9.00
EPS in Rs
2.26
2.23
2.49
2.68
2.05
2.33
2.03
1.68
1.93
1.88
1.44
1.42
1.10
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
887.00 783.00 709.00 522.00 520.00 563.00 412.00 465.00 463.00 438.00 611.00 587.00
Expenses
716.00 643.00 592.00 467.00 405.00 442.00 332.00 375.00 369.00 363.00 522.00 500.00
Operating Profit
171.00 140.00 117.00 55.00 115.00 121.00 80.00 90.00 93.00 75.00 89.00 86.00
OPM %
19.00 18.00 16.00 10.00 22.00 22.00 19.00 19.00 20.00 17.00 15.00 15.00
Other Income
8.00 6.00 4.00 5.00 5.00 3.00 5.00 3.00 2.00 1.00 4.00 16.00
Interest
23.00 19.00 24.00 22.00 19.00 11.00 12.00 12.00 15.00 16.00 17.00 18.00
Depreciation
40.00 34.00 32.00 32.00 32.00 22.00 22.00 19.00 20.00 19.00 19.00 17.00
Profit before tax
116.00 93.00 66.00 6.00 69.00 91.00 51.00 62.00 60.00 42.00 56.00 67.00
Tax %
25.00 27.00 25.00 26.00 1.00 33.00 36.00 34.00 33.00 14.00 26.00 48.00
Net Profit
88.00 68.00 49.00 4.00 68.00 61.00 33.00 41.00 40.00 36.00 42.00 35.00
EPS in Rs
9.35 7.71 5.83 0.48 8.03 7.20 3.86 4.89 4.78 4.20 4.92 4.15
Dividend Payout %
4.00 5.00 7.00 62.00 4.00 4.00 6.00 5.00 5.00 5.00 4.00 5.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
9.00 9.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00
Reserves
795.00 664.00 562.00 487.00 485.00 420.00 359.00 331.00 293.00 254.00 286.00 246.00
Borrowings
365.00 311.00 281.00 254.00 263.00 255.00 157.00 144.00 146.00 149.00 204.00 167.00
Other Liabilities
211.00 202.00 217.00 165.00 126.00 147.00 103.00 93.00 72.00 89.00 158.00 119.00
Total Liabilities
1,381.00 1,186.00 1,068.00 914.00 883.00 830.00 627.00 577.00 519.00 501.00 656.00 540.00
Fixed Assets
534.00 533.00 437.00 412.00 438.00 457.00 280.00 281.00 279.00 290.00 370.00 277.00
CWIP
116.00 35.00 30.00 33.00 11.00 7.00 42.00 18.00 8.00 8.00 13.00 29.00
Investments
52.00 45.00 45.00 45.00 45.00 45.00 45.00 45.00 45.00 37.00 21.00 13.00
Other Assets
679.00 573.00 556.00 424.00 389.00 321.00 259.00 232.00 187.00 166.00 252.00 221.00
Total Assets
1,381.00 1,186.00 1,068.00 914.00 883.00 830.00 627.00 577.00 519.00 501.00 656.00 540.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
61.00 82.00 50.00 22.00 45.00 90.00 40.00 50.00 32.00 73.00 61.00 59.00
Cash from Investing Activity
-132.00 -123.00 -52.00 -30.00 -27.00 -152.00 -43.00 -35.00 -17.00 -39.00 -79.00 -55.00
Cash from Financing Activity
76.00 47.00 31.00 -32.00 -12.00 92.00 -2.00 -13.00 -15.00 -33.00 27.00 -10.00
Net Cash Flow
4.00 5.00 29.00 -39.00 6.00 31.00 -5.00 2.00 0.00 1.00 9.00 -6.00
Free Cash Flow
-64.00 -42.00 -2.00 -7.00 18.00 -61.00 -3.00 15.00 23.00 50.00 -27.00 11.00
CFO/OP %
50.00 73.00 56.00 49.00 52.00 88.00 65.00 70.00 46.00 110.00 93.00 75.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
89.00 95.00 122.00 104.00 34.00 68.00 43.00 20.00 19.00 18.00 36.00 37.00
Inventory Days
259.00 238.00 201.00 243.00 333.00 148.00 191.00 170.00 135.00 114.00 106.00 81.00
Days Payable
89.00 95.00 130.00 117.00 97.00 70.00 66.00 59.00 49.00 82.00 79.00 58.00
Cash Conversion Cycle
259.00 238.00 192.00 230.00 270.00 146.00 169.00 131.00 105.00 50.00 63.00 61.00
Working Capital Days
98.00 88.00 85.00 104.00 94.00 48.00 57.00 39.00 27.00 -2.00 19.00 19.00
ROCE %
13.00 12.00 11.00 4.00 12.00 17.00 13.00 16.00 18.00 13.00 16.00 21.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
68.07
68.07
68.07
68.07
66.27
66.27
64.67
64.67
64.67
64.67
64.32
64.32
FIIs
0.65
0.31
0.04
0.28
0.03
0.08
0.31
0.52
0.18
0.17
0.59
0.60
DIIs
2.83
3.02
3.21
2.88
3.03
2.43
2.55
2.55
2.13
1.98
0.00
0.00
Public
28.45
28.60
28.69
28.77
30.68
31.23
32.47
32.27
33.03
33.18
35.10
35.07
No. of Shareholders
31,489
32,397
34,378
34,157
33,652
35,332
34,973
33,136
31,780
30,140
25,341
25,246
Corporate Actions
28 records
Back to all stocks